Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R D Shytle

Showing results (1-10 of 21) with videos related to

Pageof 3
Sort By:
JAMA|June 8, 1999
Adding behavioral therapy to medication for smoking cessationJ Goldman, R D Shytle, P R Sanberg
Behavioural Pharmacology|April 26, 2000
Locomotor behavioral effects of prenatal and postnatal nicotine exposure in rat offspringM B Newman, R D Shytle, P R Sanberg
Journal of Child and Adolescent Psychopharmacology|August 10, 2000
Mecamylamine in Tourette's syndrome: a two-year retrospective case studyA A Silver, R D Shytle, P R Sanberg
Biological Psychiatry|November 18, 2000
Comorbid bipolar disorder in Tourette's syndrome responds to the nicotinic receptor antagonist mecamylamine (Inversine)R D Shytle, A A Silver, P R Sanberg
Nature|November 7, 1996
Nicotine, tobacco and addictionR D Shytle, A A Silver, P R Sanberg
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|November 1, 1995
Nicotine blocks kainic acid-induced wet dog shakes in ratsR D Shytle, C V Borlongan, P R Sanberg
The Journal of Pharmacology and Experimental Therapeutics|April 17, 2001
Analysis of mecamylamine stereoisomers on human nicotinic receptor subtypesR L Papke, P R Sanberg, R D Shytle
Lancet (London, England)|September 5, 1998
Treatment of Tourette's syndrome with mecamylamineP R Sanberg, R D Shytle, A A Silver
Life Sciences|November 20, 2001
Nicotine induced seizures blocked by mecamylamine and its stereoisomersM B Newman, J J Manresa, P R Sanberg, et al.
Journal of the American Academy of Child and Adolescent Psychiatry|December 1, 1996
Case study: long-term potentiation of neuroleptics with transdermal nicotine in Tourette's syndromeA A Silver, R D Shytle, M K Philipp, et al.
Pageof 3

Showing results (1-10 of 21) with videos related to

Sort By:
Pageof 3
JAMA|June 8, 1999
Adding behavioral therapy to medication for smoking cessationJ Goldman, R D Shytle, P R Sanberg
Behavioural Pharmacology|April 26, 2000
Locomotor behavioral effects of prenatal and postnatal nicotine exposure in rat offspringM B Newman, R D Shytle, P R Sanberg
Journal of Child and Adolescent Psychopharmacology|August 10, 2000
Mecamylamine in Tourette's syndrome: a two-year retrospective case studyA A Silver, R D Shytle, P R Sanberg
Biological Psychiatry|November 18, 2000
Comorbid bipolar disorder in Tourette's syndrome responds to the nicotinic receptor antagonist mecamylamine (Inversine)R D Shytle, A A Silver, P R Sanberg
Nature|November 7, 1996
Nicotine, tobacco and addictionR D Shytle, A A Silver, P R Sanberg
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|November 1, 1995
Nicotine blocks kainic acid-induced wet dog shakes in ratsR D Shytle, C V Borlongan, P R Sanberg
The Journal of Pharmacology and Experimental Therapeutics|April 17, 2001
Analysis of mecamylamine stereoisomers on human nicotinic receptor subtypesR L Papke, P R Sanberg, R D Shytle
Lancet (London, England)|September 5, 1998
Treatment of Tourette's syndrome with mecamylamineP R Sanberg, R D Shytle, A A Silver
Life Sciences|November 20, 2001
Nicotine induced seizures blocked by mecamylamine and its stereoisomersM B Newman, J J Manresa, P R Sanberg, et al.
Journal of the American Academy of Child and Adolescent Psychiatry|December 1, 1996
Case study: long-term potentiation of neuroleptics with transdermal nicotine in Tourette's syndromeA A Silver, R D Shytle, M K Philipp, et al.
Pageof 3